FIELD: genetic engineering.
SUBSTANCE: invention refers to genetic engineering and can be used in medical and biologic industry for making recombinant heterocarpine that is an antagonist of human release factor of growth hormone (GHRH). There is disclosed complete nucleotide sequence coding polypeptide heterocarpine; there are disclosed the related primer sequences to be used in heterocarpine gene cloning, as well as genetic make-ups including specified sequence, particularly hybrid gene coding fused protein containing polypeptide heterocarpine, as well as expression vectors for said hybrid gene. There is described method for making recombinant heterocarpine as His-tag fused protein, providing application of the host cells transformed or transfected with the disclosed genetic make-ups.
EFFECT: recombinant heterocarpine according to the invention can be used in making a medicinal agent for cancer treatment.
9 cl, 6 ex
| Title |
Year |
Author |
Number |
| POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION |
2002 |
- Ferrandi Ehrik
- Kamara I Ferrer Khose-Antonio
- Martine Zhan
- Tjur'O Kristof
|
RU2307666C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND PREDICTING PULMONARY CANCER |
2001 |
- Rid Stiven Dzh.
- Lodes Majkl Dzh.
- Mokhamat Roodokh
- Sekrist Khiter
- Benson Dehrin R.
- Indirias Kehrol Jozef
- Khenderson Robert A.
- Fling Stiven P.
- Ehlgejt Pol A.
- Ehlliot Mark
- Mehnnion Dzhejn
- Kalos Majkl D.
|
RU2311920C2 |
| NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR |
2002 |
|
RU2316591C2 |
| COMPOSITIONS AND METHODS OF MAMMARY GLAND CANCER THERAPY AND DIAGNOSTICS |
2001 |
- Dziang Jukiu
- Dillon Dehvin K.
- Mitcham Dzhennifer L.
- Ksu Dziangchun
- Kharloker Sjuzan L.
- Khehpler Uill'Jam T.
|
RU2344831C2 |
| COMPOSITIONS AND METHODS RELATED TO SOLUBLE G-PROTEIN CONJUGATE RECEPTORS (SGPCR) |
2006 |
- Chen Alon
- Perrin Mehrilin
- Vehjl Uajli
|
RU2423378C2 |
| DPPIV-COGNATED NEW SERINE PROTEASE GENE |
2001 |
- Ki Stiv
- Akinsan'Ja Karen O.
- Riv'Er P'Er Zh.-M.
- Zhjun'En Zhan-Lui
|
RU2305133C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE |
1995 |
|
RU2164419C2 |
| TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA |
2011 |
- Kollard Dzhozef
- Khorkova Sherman Olga
- De Leon Belinda
- Kojto Karlos
- Khsyao Dzhejn Kh., Dr.
|
RU2588654C2 |
| COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY |
1999 |
- Gehjdzher Aleksandr
- Chiver Martin
|
RU2237674C2 |
| G-PROTEIN COUPLED RECEPTORS DROSOPHILA, NUCLEIC ACIDS AND RELATED METHODS |
2003 |
- Louehri Dehvid Eh.
- Smit Valdin G.
- Kubjak Tereza M.
- Larsen Marta Dzh.
|
RU2326385C2 |
